Durata Therapeutics, Inc. (DRTX) [Rocket]

In millions, except per share items	Dec-31-13	Nov-04-13	Dec-31-12	Nov-04-12	Dec-31-11	Dec-31-10
	10-K	10-K	10-K	10-K	10-K	10-K
Revenues [+]	2.2	340.3	0.0	226.3	71.1	27.8
Net interest income	2.2
Revenue growth		50.3%	-100.0%		155.9%
Cost of goods sold	-115.6	0.0	-125.1	0.0	0.0	0.0
Gross profit	117.8	340.3	125.1	226.3	71.1	27.8
Gross margin	5293.6%	100.0%		100.0%	100.0%	100.0%
Selling, general and administrative [+]	18.6	36.4	9.8	17.8	4.3	2.8
General and administrative	18.6	36.4	9.8	17.8	4.3	2.8
Research and development	37.3	124.2	51.7	86.8	30.1	4.8
Other operating expenses	3.9		0.0
EBITDA [+]	58.3	180.0	63.7	121.7
EBITDA growth	-8.5%	47.9%	73.6%		81.6%
EBITDA margin	2618.1%	52.9%		53.8%	51.6%	72.7%
Depreciation and amortization	0.3	0.3	0.0	0.0
EBIT [+]	58.0	179.7	63.7	121.7	36.7	20.2
EBIT growth	-8.9%	47.7%	73.6%		81.6%
EBIT margin	2606.7%	52.8%		53.8%	51.6%	72.7%
Non-recurring items	1.1	9.6	1.1	8.5	1.1	6.3
Interest expense, net [+]	-0.1	2.1	0.0	-0.1	0.0	0.0
Interest expense		2.2
Interest income	0.1	0.1	0.0	0.1	0.0	0.0
Other income (expense), net [+]	3.8	5.9	-0.1	-0.1	0.0	0.0
Gain (loss) on debt retirement	2.2
Other	-0.5
Pre-tax income	60.9	174.0	62.5	113.1	35.5	13.9
Income taxes	1.3	-4.5	0.0	-5.8	-2.5	-2.9
Tax rate	2.1%		0.0%
Net income	-62.1	-169.4	-62.5	-107.3	-33.0	-11.0
Net margin	-2791.6%	-49.8%		-47.4%	-46.4%	-39.6%

Basic EPS [+]	($2.57)		($7.48)		($551.51)	($469.91)
Growth	-65.7%		-98.6%		17.4%
Diluted EPS [+]	($2.57)		($7.48)		($551.51)	($469.91)
Growth	-65.7%		-98.6%		17.4%

Shares outstanding (basic) [+]	24.2		8.4		0.1	0.0
Growth	189.6%		13864.9%		155.6%
Shares outstanding (diluted) [+]	24.2		8.4		0.1	0.0
Growth	189.6%		13864.9%		155.6%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.